HOLLY LOCKMAN: Open Payments
NPI 1639958432 · RAPID CITY, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 40 payments from 8 companies in 2025. Trend: 2023 $188 · 2024 $1,188 · 2025 $816
Food & beverage: $816
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $212 |
| Alkermes, Inc. | 8 | $175 |
| Teva Pharmaceuticals USA, Inc. | 4 | $164 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $96 |
| Neurocrine BioSciences, Inc. | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
Products named: VRAYLAR, UZEDY, LYBALVI, CAPLYTA, ARISTADA, INGREZZA, COBENFY, ABILIFY ASIMTUFII.
Industry payments across SD — which companies pay providers there.
